AU2453697A - Use of photopheresis in the treatment of chronic infection by hepatitis c virus - Google Patents
Use of photopheresis in the treatment of chronic infection by hepatitis c virusInfo
- Publication number
- AU2453697A AU2453697A AU24536/97A AU2453697A AU2453697A AU 2453697 A AU2453697 A AU 2453697A AU 24536/97 A AU24536/97 A AU 24536/97A AU 2453697 A AU2453697 A AU 2453697A AU 2453697 A AU2453697 A AU 2453697A
- Authority
- AU
- Australia
- Prior art keywords
- photopheresis
- hepatitis
- virus
- treatment
- chronic infection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0066—Psoralene-activated UV-A photochemotherapy (PUVA-therapy), e.g. for treatment of psoriasis or eczema, extracorporeal photopheresis with psoralens or fucocoumarins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
- A61K31/37—Coumarins, e.g. psoralen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1522596P | 1996-04-10 | 1996-04-10 | |
US60015225 | 1996-04-10 | ||
PCT/US1997/005966 WO1997037654A1 (en) | 1996-04-10 | 1997-04-10 | Use of photopheresis in the treatment of chronic infection by hepatitis c virus |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2453697A true AU2453697A (en) | 1997-10-29 |
Family
ID=21770194
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU24536/97A Abandoned AU2453697A (en) | 1996-04-10 | 1997-04-10 | Use of photopheresis in the treatment of chronic infection by hepatitis c virus |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2453697A (en) |
WO (1) | WO1997037654A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000510003A (en) * | 1996-03-29 | 2000-08-08 | セラコス・インコーポレーテツド | Photopheresis treatment of chronic HCV infection |
IL126366A (en) * | 1996-03-29 | 2011-10-31 | Therakos Inc | Use of a photoactivatable compound in the manufacture of a medicament for the treatment of an infection |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5399719A (en) * | 1993-06-28 | 1995-03-21 | Steritech, Inc. | Compounds for the photodecontamination of pathogens in blood |
-
1997
- 1997-04-10 AU AU24536/97A patent/AU2453697A/en not_active Abandoned
- 1997-04-10 WO PCT/US1997/005966 patent/WO1997037654A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1997037654A1 (en) | 1997-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0707855A3 (en) | Combination therapy for chronic hepatitis C infection | |
AU2064297A (en) | Hepatitis c virus ribozymes | |
AU7846694A (en) | Adjustable treatment chamber catheter | |
HK1037981A1 (en) | Use of peg-ifn-alpha and ribavirin for the treatment of chronic hepatitis C. | |
AU3434393A (en) | Targeted virus | |
AU2568800A (en) | Tubing for extracorporal purification of the blood and use thereof | |
AU2550995A (en) | Hepatitis c virus asialoglycoproteins | |
IL129352A0 (en) | Benzimidazole-2- carbamates for the treatment of viral infections and cancer | |
AU7567394A (en) | Treatment chamber catheter | |
AU2158000A (en) | Treatment of hepatitis c virus infections with interleukin-10 | |
AU2549797A (en) | Xanthone analogs for the treatment of infectious diseases | |
AU5618501A (en) | Dihydropyrimidines and the use thereof as medicaments for the treatment of hepatitis | |
AU7099198A (en) | Use of amantadine for treatment of hepatitis c | |
IL162236A0 (en) | Purified hepatitis c virus envelopeproteins for dagnostic and therapeutic use | |
AU5758594A (en) | Treatment of viral infections | |
AU4985596A (en) | Novel aroylaniline derivatives, compositions and uses thereof in the treatment of viral infections | |
AU2281601A (en) | Treatment of viral infections using levovirinTM | |
AU5679394A (en) | Hepatitis b virus vaccines | |
AU2001232053A1 (en) | System for the extracorporeal treatment of blood | |
AU2453697A (en) | Use of photopheresis in the treatment of chronic infection by hepatitis c virus | |
AU3530395A (en) | Treatment of viral infections | |
FI965196A0 (en) | Combination therapy for HIV infection | |
AU3064800A (en) | The therapeutic use of r-warfarin as anticoagulant | |
AU6130194A (en) | 1,2-dithiole-3-thiones for the treatment of reverse transcriptase-dependent viral infections | |
AU1389897A (en) | Use of chemokines for the treatment and prevention of hiv infection |